A new partnership is calling for early-stage life science ventures in the UK to apply for specialist support ahead of investment rounds.
BioCity, Innovate UK, the National Institute for Health Research, NHS England and NHS Improvement’s SBRI Healthcare programme have announced a new partnership to support life science ventures to get investment ready.
The organisations have launched a new Investment Readiness Programme specifically designed for MedTech, diagnostic and digital health ventures seeking to raise seed or series A follow-on funding.
Offered exclusively for entrepreneurs which have previously been awarded funding through Innovate UK, SBRI Healthcare, nihr I4I or an AI in health and care award, the programme will support those looking for investment between £100,000 and £2m.
The programme will encompass a series of one-to-one sessions and workshops culminating in an online investment showcase.
Colin Roberts, BioCity director of venture development, said: “Although many entrepreneurs will have experience with family and friends or pre-seed rounds, follow-on rounds come with unique challenges. Getting those decisions right is crucial to a firm’s trajectory.
“The programme has been specially designed to support MedTech, diagnostic and digital health, including service delivery, ventures to successfully engage investors needed to support their future growth, commercialise scientific discovery and solve global health and environmental challenges.
“If the last 12 months have taught us anything, it is that solutions to many of our current problems are within the hands of the scientific community.
“Our ultimate aim is to help them make sure those solutions make it out of the lab and into the world.”
Applications for the programme are now open and will close on Monday 22 February 2021.